Table 1.
Demographic and clinical data and SARS-CoV-2 lineages of fully vaccinated vs nonvaccinated COVID-19 cases with full SARS-CoV-2 genomes
| FullyVaccinated | Unvaccinated | |
|---|---|---|
| Age | ||
| Median | 37 | 42 |
| Range | 22–90 | <l-96 |
| Age Groups* | ||
| <20 | 0 | 39 (13.8) |
| 20–29 | 31 (23.5) | 45 (15.9) |
| 30–39 | 42 (31.8) | 49 (17.3) |
| 40–49 | 13 (9.8) | 31 (10.9) |
| 50–59 | 19 (14.4) | 45 (15.9) |
| 60–69 | 13 (9.8) | 31 (10.9) |
| 70–79 | 8 (6.1) | 18 (6.4) |
| 80–89 | 5 (3.8) | 21 (7.4) |
| >90 | 1 (0.7) | 4 (1.4) |
| Sex | ||
| Male | 67 | 133 |
| Female | 65 | 155 |
| Vaccine Type | ||
| Pfizer | 115 | Not applicable |
| Moderna | 14 | Not applicable |
| Janssen | 3 | Not applicable |
| Days after vaccination | ||
| Median | 136 | Not applicable |
| Range | 21–221 | |
| <120 | 49 | Notapplicable |
| >120 | 83 | Notapplicable |
| Hospitalized | 8 (6) | 83 (29) |
| Symptomatic | 72 (54.5) | 207 (84.1)# |
| SARS-CoV-2variant | ||
| Alpha | 13 (9.8) | 68 (24.0) |
| lota | 7 (5.3) | 35 (12.4) |
| Gamma | 4 (3.0) | 19 (6.7) |
| Delta | 101 (76.5) | 139 (49.1) |
| Other | 7 (5.3) | 22 (7.8) |
| Total Cases | 132 | 283 |
All figures are absolute numbers except numbers in parenthesis are % from total cases.
#
information available for 246/283 unvaccinated individuals.